Jointly provided by AXIS Medical Education and Novus Medical Education.
This activity is supported by an independent education grant from Otsuka America Pharmaceutical, Inc.
Target Audience: This activity is intended for psychiatrists and other mental health professionals who provide care for patients suffering from depression.
Program Overview: Major depressive disorder (MDD) is a debilitating condition that approximately 1 in 5 people in the United States will experience at some point in their life, yet up to 60% of patients do not attain an adequate response from their initial antidepressant treatment. Clinicians have historically struggled to agree on when a patient should be considered non- or partially-responsive, and the APA’s practice guidelines for treating patients with MDD stops short of providing a definitive answer. It is critical for clinicians to recognize when a modification to therapy should be made, and to have the decision making skills to evaluate and select appropriate alternatives.
This series consists of 2 continuing education modules
Module 2 Patient Case: Suzanne, 45, Suffering from Depression